Evaluation of the size and area of the corpus callosum with the osiris method in alzheimer's disease

Neurodegenerative Diseases

Volumn 6, Issue 4, 2009, Pages 148-153

  Kabay, Sibel Canbaz ^a   Gulbandilar, Eyup ^a   Ozden, Hilmi ^c   Ozbag, Davut ^b   Guven, Gul ^c   Adapinar, Baki ^c   Durmaz, Ramazan ^c  

^a DUMLUPINAR UNIVERSITY   (Turkey)

^b KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

^c ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Alzheimer's disease; Corpus callosum; Dementia; Magnetic resonance imaging; Mini Mental Status Examination; Osiris method

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; COMPUTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; CORPUS CALLOSUM; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CORPUS CALLOSUM; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 69249222562     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000225375     Document Type: Article

References (31)

1. Hartmann T, Kuchenbecker J, Grimm MO: Alzheimer's disease: the lipid connection. J Neurochem 2007; 103: 159-170.
2. Cummings JL, Cole G: Alzheimer disease. JAMA 2002; 287: 2335-2338.
3. Pantel J, Schröder J, Jauss M, Essig M, Minakaran R, Schönknecht P, Schneider G, Schad LR, Knopp MV: Topography of callosal atrophy reflects distribution of regional cerebral volume reduction in Alzheimer's disease. Psychiatry Res 1999; 90: 181-192.
4. Teipel SJ, Bayer W, Alexander GE, Zebuhr Y, Teichberg D, Kulic L, Schapiro MB, Möller HJ, Rapoport SI, Hampel H: Progression of corpus callosum atrophy in Alzheimer disease. Arch Neurol 2002; 59: 243-248.
5. Teipel SJ, Bayer W, Alexander GE, Bokde AL, Zebuhr Y, Teichberg D, Müller-Spahn F, Schapiro MB, Möller HJ, Rapoport SI, Hampel H: Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration. Neurobiol Aging 2003; 24: 85-94.
6. Gazzaniga MS: Cerebral specialization and interhemispheric communication: does the corpus callosum enable the human condition? Brain 2000; 123: 1293-1326.
7. Baron JC, Chételat G, Desgranges B, Perchey G, Landeau B, de la Sayette V, Eustache F: In vivo mapping of gray matter loss with voxelbased morphometry in mild Alzheimer's disease. NeuroImage 2001; 14: 298-309.
8. Salat DH, Kaye JA, Janowsky JS: Prefrontal gray and white matter volumes in healthy aging and Alzheimer's disease. Arch Neurol 1999; 56: 338-344.
9. Janowsky JS, Kaye JA, Carper RA: Atrophy of the corpus callosum in Alzheimer's disease versus healthy aging. J Am Geriatr Soc 1996; 44: 798-803.
10. Hampel H, Teipel SJ, Alexander GE, Horwitz B, Teichberg D, Schapiro MB, Rapoport SI: Corpus callosum atrophy is a possible indicator of region- and cell-type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. Arch Neurol 1998; 55: 193-198.
11. Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Hayashi T, Oyanagi C, Konishi J, Shio H: Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2000; 69: 623-629.
12. Good CD, Scahill RI, Fox NC, Ashburner J, Friston KJ, Chan D, Crum WR, Rossor MN, Frackowiak RS: Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage 2002; 17: 29-46.
13. Chaim TM, Duran FL, Uchida RR, Périco CA, de Castro CC, Busatto GF: Volumetric reduction of the corpus callosum in Alzheimer's disease in vivo as assessed with voxel-based morphometry. Psychiatry Res 2007; 154: 59-68.
14. Ligier Y, Ratib O, Logean M, Girard C: Osiris: a medical image-manipulation system. MD Comput 1994; 11: 212-218.
15. Bird P, Lassere M, Shnier R, Edmonds J: Computerized measurement of magnetic resonance imaging erosion volumes in patients with rheumatoid arthritis: a comparison with existing magnetic resonance imaging scoring systems and standard clinical outcome measures. Arthritis Rheum 2003; 48: 614-624.
16. Dφhn UM, Ejbjerg BJ, Hasselquist M, Narvestad E, Court-Payen M, Szkudlarek M, Mφller J, Thomsen HS, Ostergaard M: Rheumatoid arthritis bone erosion volumes on CT and MRI: reliability and correlations with erosion scores on CT, MRI and radiography. Ann Rheum Dis 2007; 66: 1388-1392.
17. Folstein MF, Folstein SE, McHugh PR: Minimental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
18. Thompson PM, Hayashi KM, De Zubicaray GI, Janke AL, Rose SE, Semple J, Hong MS, Herman DH, Gravano D, Doddrell DM, Toga AW: Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage 2004; 22: 1754-1766.
19. Duan J, Wang H, Xu J, Lin X, Chen SQ, Kang Z, Yao ZB: White matter damage of patients with Alzheimer's disease correlated with the disease cognitive function. Surg Radiol Anat 2006; 28: 150-156.
20. Apostolova L, Dutton R, Dinov I, Hayashi KM, Toga AW, Cummings JL, Thompson PM: Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol 2006; 63: 693-699.
21. Baxter L, Sparks D, Johnson S, Lenoski B, Lopez JE, Connor DJ, Sabbagh MN: Relationship of cognitive measures and gray and white matter in Alzheimer's disease. J Alzheimers Dis 2006; 9: 253-260.
22. Apostolova LG, Lu PH, Rogers S, Dutton RA, Hayashi KM, Toga AW, Cummings JL, Thompson PM: 3D mapping of Mini-Mental State Examination performances in clinical and preclinical Alzheimer disease. Alzheimer Dis Assoc Disord 2006; 20: 224-231.
23. McKhann G, Drachman D, Folstein M Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939-944.
24. Güngen C, Ertan T, Eker E, Yasar R, Engin F: Reliability and validity of the standardized Mini-Mental State Examination in the diagnosis of mild dementia in the Turkish population. Türk Psikiyatri Derg 2002; 13: 273-281.
25. Gootjes L, Bouma A, Van Strien JW, Van Schijndel R, Barkhof F, Scheltens P: Corpus callosum size correlates with asymmetric performance on a dichotic listening task in healthy aging but not in Alzheimer's disease. Neuropsychologia 2006; 44: 208-217.
26. Hensel A, Wolf H, Kruggel F, Riedel-Heller SG, Nikolaus C, Arendt T, Gertz HJ: Morphometry of the corpus callosum in patients with questionable and mild dementia. J Neurol Neurosurg Psychiatry 2002; 73: 59-61.
27. Thomann PA, Wustenberg T, Pantel J, Essig M, Schroder J: Structural changes of the corpus callosum in mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord 2006; 21: 215-220.
28. Lyoo IK, Satlin A, Lee CK, Renshaw PF: Regional atrophy of the corpus callosum in subjects with Alzheimer's disease and multiinfarct dementia. Psychiatry Res 1997; 16: 63-72.
29. Rose SE, Chen F, Chalk JB, Zelaya FO, Strugnell WE, Benson M, Semple J, Doddrell DM: Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with color coded MR diffusion tensor imaging. J Neurol Neurosurg Psychiatry 2000; 69: 528-530.
30. Tomaiuolo F, Scapin M, Di Paola M, Le Nezet P, Fadda L, Musicco M, Caltagirone C, Collins DL: Gross anatomy of the corpus callosum in Alzheimer's disease: regions of degeneration and their neuropsychological correlates. Dement Geriatr Cogn Disord 2007; 23: 96-103.
31. Hensel A, Ibach B, Muller U, Kruggel F, Kiefer M, Gertz HJ: Does the pattern of atrophy of the corpus callosum differ between patients with frontotemporal dementia and patients with Alzheimer's disease? Dement Geriatr Cogn Disord 2004; 18: 44-49.